Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency
- 1 July 1978
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 10 (3) , 262-269
- https://doi.org/10.1016/0090-1229(78)90180-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Cellular immunodeficiency associated with nucleoside phosphorylase deficiencyClinical Immunology and Immunopathology, 1977
- Purine Nucleoside Phosphorylase Deficiency Associated with Selective Cellular ImmunodeficiencyNew England Journal of Medicine, 1977
- Abnormal Purine Metabolism and Purine Overproduction in a Patient Deficient in Purine Nucleoside PhosphorylaseNew England Journal of Medicine, 1976
- Enzyme Replacement Therapy for Adenosine Deaminase Deficiency and Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1976
- Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5Biochemical and Biophysical Research Communications, 1976
- Intracellular 5-Phosphoribosyl-1-Pyrophosphate: Decreased Availability During Glutamine LimitationScience, 1976
- NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITYThe Lancet, 1975
- Severe Combined Immunodeficiency and Adenosine Deaminase DeficiencyNew England Journal of Medicine, 1975
- Thymosin Activity in Patients with Cellular ImmunodeficiencyNew England Journal of Medicine, 1975
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972